Remberger, M <br/><br/>
Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose.  [electronic resource] 

 -  Bone marrow transplantation  Dec 2008 
 - 769-71 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2008.246  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antilymphocyte Serum--immunology<br/>Antineoplastic Agents--therapeutic use<br/>Female<br/>HLA Antigens--immunology<br/>Hematopoietic Stem Cells--immunology<br/>Humans<br/>Leukemia--therapy<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Siblings<br/>Stem Cell Transplantation<br/>Transplantation Conditioning--methods<br/>Vidarabine--analogs & derivatives